The Role of Physical Therapy in Slowing Cognitive Deficits in Patients with Alzheimer’s disease

Author's Information:

Isha Bhonde

Jersey City, USA

Vol 05 No 03 (2025):Volume 05 Issue 03 March 2025

Page No.: 57-60

Abstract:

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline, impairing memory, reducing executive function, loss of functional independence, and reduced quality of life. [1] At present it is a growing globally and is considered a global public health priority as per WHO with huge implications on the society. [2] Treatment with pharmacological drugs aims to manage the disease symptomatically. [3] Non-pharmacological interventions such as physical therapy (PT), cognitive rehabilitation, occupational therapy, etc are gaining importance as supportive therapies in managing the disease. [4] Physical therapy (PT) has been recognized as a valuable intervention in slowing cognitive deficits and preserving functional abilities in individuals with AD. Regular physical activity enhances cerebral blood flow, promotes neuroplasticity, and reduces the risk of comorbidities that exacerbate cognitive deterioration. [5] Additionally, PT interventions improve gait stability, reduce fall risk, and support activities of daily living, fostering greater independence and social engagement. [6] Integrating PT into multidisciplinary care may offer a non-invasive, effective strategy to slow cognitive decline and enhance the well-being of AD patients.

KeyWords:

Alzheimer’s disease, cognitive decline, Physical exercise

References:

  1. It, K., & KNOW, W. (1986). What is Alzheimer’s disease. N Engl] Med314, 964-973.
  2. Lane, C. A., Hardy, J., & Schott, J. M. (2018). Alzheimer's disease. European journal of neurology25(1), 59-70.
  3. Herrmann, N., Chau, S. A., Kircanski, I., & Lanctot, K. L. (2011). Current and emerging drug treatment options for Alzheimer’s disease: a systematic review. Drugs71, 2031-2065.
  4. Zucchella, C., Sinforiani, E., Tamburin, S., Federico, A., Mantovani, E., Bernini, S., ... & Bartolo, M. (2018). The multidisciplinary approach to Alzheimer's disease and dementia. A narrative review of non-pharmacological treatment. Frontiers in neurology9, 1058.
  5. Phillips, C., Akif Baktir, M., Das, D., Lin, B., & Salehi, A. (2015). The link between physical activity and cognitive dysfunction in Alzheimer disease. Physical Therapy95(7), 1046-1060.
  6. Gras, L. Z., Kanaan, S. F., McDowd, J. M., Colgrove, Y. M., Burns, J., & Pohl, P. S. (2015). Balance and gait of adults with very mild Alzheimer disease. Journal of geriatric physical therapy38(1), 1-7.
  7. Moya-Alvarado, G., Gershoni-Emek, N., Perlson, E., & Bronfman, F. C. (2016). Neurodegeneration and Alzheimer's disease (AD). What can proteomics tell us about the Alzheimer's brain?. Molecular & Cellular Proteomics15(2), 409-425.
  8. Nelson, L., & Tabet, N. (2015). Slowing the progression of Alzheimer’s disease; what works?. Ageing research reviews23, 193-209.
  9. Tahami Monfared, A. A., Byrnes, M. J., White, L. A., & Zhang, Q. (2022). Alzheimer’s disease: epidemiology and clinical progression. Neurology and therapy11(2), 553-569.
  10. Mayeux, R., & Stern, Y. (2012). Epidemiology of Alzheimer disease. Cold Spring Harbor perspectives in medicine2(8), a006239.
  11. Masters, C. L., Bateman, R., Blennow, K., Rowe, C. C., Sperling, R. A., & Cummings, J. L. (2015). Alzheimer's disease. Nature reviews disease primers1(1), 1-18.
  12. Armstrong, R. A. (2013). What causes Alzheimer’s disease?. Folia neuropathologica51(3), 169-188.
  13. López, O. L., & DeKosky, S. T. (2008). Clinical symptoms in Alzheimer's disease. Handbook of clinical neurology89, 207-216.
  14. Li, X. L., Hu, N., Tan, M. S., Yu, J. T., & Tan, L. (2014). Behavioral and psychological symptoms in Alzheimer’s disease. BioMed research international2014(1), 927804.
  15. Bhushan, I., Kour, M., Kour, G., Gupta, S., Sharma, S., & Yadav, A. (2018). Alzheimer’s disease: Causes & treatment–A review. Ann Biotechnol1(1), 1002.
  16. Yaari, R., & Corey-Bloom, J. (2007, February). Alzheimer's disease. In Seminars in neurology (Vol. 27, No. 01, pp. 032-041). Copyright© 2007 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.
  17. Vaz, M., & Silvestre, S. (2020). Alzheimer's disease: Recent treatment strategies. European journal of pharmacology887, 173554.
  18. Javed, B., Javed, A., Kow, C. S., & Hasan, S. S. (2023). Pharmacological and non-pharmacological treatment options for sleep disturbances in Alzheimer’s disease. Expert review of neurotherapeutics23(6), 501-514.
  19. Chen, W. W., Zhang, X., & Huang, W. J. (2016). Role of physical exercise in Alzheimer's disease. Biomedical reports4(4), 403-407.
  20. Frederiksen, K. S., Gjerum, L., Waldemar, G., & Hasselbalch, S. G. (2017). Effects of physical exercise on Alzheimer’s disease biomarkers: a systematic review of intervention studies. Journal of Alzheimer’s Disease61(1), 359-372.
  21. Paillard, T., Rolland, Y., & de Souto Barreto, P. (2015). Protective effects of physical exercise in Alzheimer's disease and Parkinson's disease: a narrative review. Journal of clinical neurology11(3), 212-219.
  22. Cámara-Calmaestra, R., Martínez-Amat, A., Aibar-Almazán, A., Hita-Contreras, F., de Miguel Hernando, N., & Achalandabaso-Ochoa, A. (2022). Effectiveness of physical exercise on Alzheimer’s disease. A systematic review. The Journal of Prevention of Alzheimer's Disease9(4), 601-616.
  23. Parvin, E., Mohammadian, F., Amani-Shalamzari, S., Bayati, M., & Tazesh, B. (2020). Dual-task training affect cognitive and physical performances and brain oscillation ratio of patients with Alzheimer’s disease: A randomized controlled trial. Frontiers in aging neuroscience12, 605317.
  24. Valenzuela, P. L., Castillo-García, A., Morales, J. S., de la Villa, P., Hampel, H., Emanuele, E., ... & Lucia, A. (2020). Exercise benefits on Alzheimer’s disease: State-of-the-science. Ageing research reviews62, 101108.
  25. Abd El-Kader, S. M., & Al-Jiffri, O. H. (2016). Aerobic exercise improves quality of life, psychological well-being and systemic inflammation in subjects with Alzheimer’s disease. African health sciences16(4), 1045-1055.